Variant report

Variant	rs73298018
Chromosome Location	chr17:20746810-20746811
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 54 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:41)

rs_ID	r²[population]
rs11653352	0.82[AMR][1000 genomes];0.89[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs11653660	0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs1815568	0.93[ASN][1000 genomes]
rs1815572	0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs1856276	0.86[AMR][1000 genomes];0.83[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs1974277	0.86[AMR][1000 genomes];0.86[EUR][1000 genomes];0.80[ASN][1000 genomes]
rs1999864	0.93[ASN][1000 genomes]
rs28538692	0.95[ASN][1000 genomes]
rs2958466	0.90[ASN][1000 genomes]
rs2958468	0.91[ASN][1000 genomes]
rs2958469	0.82[ASN][1000 genomes]
rs2958479	0.86[ASN][1000 genomes]
rs2993351	0.88[ASN][1000 genomes]
rs2993352	0.81[AMR][1000 genomes];0.87[ASN][1000 genomes]
rs2993353	0.85[ASN][1000 genomes]
rs2993360	0.93[ASN][1000 genomes]
rs2993361	0.90[ASN][1000 genomes]
rs2993369	0.90[ASN][1000 genomes]
rs2993370	0.86[AMR][1000 genomes];0.87[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs34695039	0.97[ASN][1000 genomes]
rs35847073	0.92[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs4359505	0.99[ASN][1000 genomes]
rs4508469	0.85[ASN][1000 genomes]
rs4517848	0.95[ASN][1000 genomes]
rs4520891	0.91[ASN][1000 genomes]
rs4985929	0.96[ASN][1000 genomes]
rs57273270	0.92[ASN][1000 genomes]
rs6587090	0.93[ASN][1000 genomes]
rs6587091	0.80[AMR][1000 genomes]
rs7207243	0.98[ASN][1000 genomes]
rs7220472	0.96[ASN][1000 genomes]
rs7221311	0.98[ASN][1000 genomes]
rs7223908	0.91[ASN][1000 genomes]
rs73982310	0.94[ASN][1000 genomes]
rs8079974	0.96[ASN][1000 genomes]
rs9891333	0.98[ASN][1000 genomes]
rs9893692	0.97[ASN][1000 genomes]
rs9905676	0.89[AMR][1000 genomes];0.98[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs9906238	0.83[ASN][1000 genomes]
rs9906250	0.83[ASN][1000 genomes]
rs9906720	0.84[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv916440	chr17:20171468-20839266	ZNF genes & repeats Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	63 gene(s)	inside rSNPs	diseases
2	esv2751619	chr17:20462908-20914156	Enhancers Weak transcription Bivalent/Poised TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	44 gene(s)	inside rSNPs	diseases
3	esv3361931	chr17:20539962-20845258	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
4	nsv469647	chr17:20552253-20751738	Flanking Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Weak transcription Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
5	nsv482489	chr17:20552253-20751738	Weak transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
6	esv3330516	chr17:20572433-20862663	Enhancers Bivalent/Poised TSS Genic enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
7	nsv1066490	chr17:20732646-20786993	Bivalent/Poised TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	3 gene(s)	inside rSNPs	diseases
8	nsv960439	chr17:20733458-20799926	Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	4 gene(s)	inside rSNPs	diseases
9	nsv1057238	chr17:20734623-20786993	Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	3 gene(s)	inside rSNPs	diseases
10	nsv1057410	chr17:20736492-20782474	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers Flanking Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	3 gene(s)	inside rSNPs	diseases
11	nsv1064007	chr17:20736492-20785902	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	3 gene(s)	inside rSNPs	diseases
12	nsv1065163	chr17:20736890-20778317	Bivalent Enhancer Enhancers Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	3 gene(s)	inside rSNPs	diseases
13	nsv1067482	chr17:20737431-20782474	Flanking Active TSS Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	3 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:40 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20745000-20747200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
2	chr17:20745400-20747000	Weak transcription	Spleen	Spleen
3	chr17:20746600-20747000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
4	chr17:20746600-20747200	Enhancers	Primary B cells from peripheral blood	blood
5	chr17:20746600-20747600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
6	chr17:20746600-20748000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
7	chr17:20746600-20748000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr17:20746800-20747000	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
9	chr17:20746800-20747000	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
10	chr17:20746800-20747000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
11	chr17:20746800-20747000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
12	chr17:20746800-20747000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
13	chr17:20746800-20747000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr17:20746800-20747000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr17:20746800-20747000	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr17:20746800-20747000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr17:20746800-20747000	Bivalent/Poised TSS	Colonic Mucosa	Colon
18	chr17:20746800-20747000	Enhancers	Esophagus	oesophagus
19	chr17:20746800-20747000	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
20	chr17:20746800-20747000	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
21	chr17:20746800-20747000	Bivalent Enhancer	Small Intestine	intestine
22	chr17:20746800-20747000	Bivalent Enhancer	Stomach Smooth Muscle	stomach
23	chr17:20746800-20747000	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
24	chr17:20746800-20747200	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
25	chr17:20746800-20747200	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
26	chr17:20746800-20747200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
27	chr17:20746800-20747200	Bivalent Enhancer	Fetal Muscle Leg	muscle
28	chr17:20746800-20747200	Enhancers	Gastric	stomach
29	chr17:20746800-20747200	Enhancers	Lung	lung
30	chr17:20746800-20747600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr17:20746800-20747600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr17:20746800-20747600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr17:20746800-20747600	Bivalent Enhancer	Adipose Nuclei	Adipose
34	chr17:20746800-20747600	Bivalent/Poised TSS	Brain Germinal Matrix	brain
35	chr17:20746800-20747600	Bivalent/Poised TSS	Fetal Brain Female	brain
36	chr17:20746800-20748000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
37	chr17:20746800-20748000	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
38	chr17:20746800-20748000	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
39	chr17:20746800-20748000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
40	chr17:20746800-20748000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links